Literature DB >> 25891712

Pretransplant serum levels of C-reactive protein predict prognoses in patients undergoing liver transplantation for hepatocellular carcinoma.

Y-K Kim1, S H Kim2, S D Lee3, S K Hong4, S-J Park3.   

Abstract

BACKGROUND: Preoperative absolute C-reactive protein (CRP) has been shown to correlate with prognoses in various malignancies, including hepatocellular carcinoma (HCC).
METHODS: The aim of this study was to investigate whether pretransplant CRP levels predict prognoses in patients undergoing liver transplantation (LT) for HCC. We retrospectively analyzed clinicopathological factors in 211 patients with available pretransplant serum CRP levels who underwent LT for HCC between January 2005 and April 2012.
RESULTS: By means of receiver operating characteristic curve analysis, a CRP level of >0.3 mg/dL was considered to be elevated. By multivariate analysis, the high CRP level, the maximal tumor size >5 cm, the presence of intrahepatic metastasis, and positive findings in pretransplant (18)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) were related to tumor recurrence, whereas the high CRP level, the presence of intrahepatic metastasis, and positive findings in pretransplant (18)F-FDG PET/CT were related to poor overall survival. When subgroup analysis was conducted according to the Milan criteria, the high CRP level was an independent factor for predicting poor outcomes in patients with HCC beyond the Milan criteria (P = .001 for recurrence-free survival and P = .010 for overall survival), and not for patients within the criteria.
CONCLUSIONS: Pretransplant serum CRP levels can predict prognoses in patients undergoing LT for HCC, especially in patients with HCC exceeding the Milan criteria.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25891712     DOI: 10.1016/j.transproceed.2014.11.048

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  8 in total

Review 1.  Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review.

Authors:  Dong-Wei Xu; Ping Wan; Qiang Xia
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

Review 2.  Role of inflammatory markers as hepatocellular cancer selection tool in the setting of liver transplantation.

Authors:  Russell E Rosenblatt; Zaid H Tafesh; Karim J Halazun
Journal:  Transl Gastroenterol Hepatol       Date:  2017-11-21

3.  Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment.

Authors:  Hiroyuki Nakanishi; Masayuki Kurosaki; Kaoru Tsuchiya; Yutaka Yasui; Mayu Higuchi; Tsubasa Yoshida; Yasuyuki Komiyama; Kenta Takaura; Tsuguru Hayashi; Konomi Kuwabara; Natsuko Nakakuki; Hitomi Takada; Masako Ueda; Nobuharu Tamaki; Shoko Suzuki; Jun Itakura; Yuka Takahashi; Namiki Izumi
Journal:  Liver Cancer       Date:  2016-09-14       Impact factor: 11.740

4.  A model integrated fibrinogen and D-dimer for prediction of hepatocellular carcinoma recurrence following liver transplantation: a multicentre study.

Authors:  Chao Wang; Zhikun Liu; Jun Chen; Wei Rao; Siyi Dong; Modan Yang; Shusen Zheng; Yunjin Zang; Xiao Xu
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

5.  Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.

Authors:  Arno Kornberg; Martina Schernhammer; Jennifer Kornberg; Helmut Friess; Katharina Thrum
Journal:  Dig Dis Sci       Date:  2018-09-27       Impact factor: 3.199

6.  C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation.

Authors:  Tobias Meischl; Susanne Rasoul-Rockenschaub; Georg Györi; Wolfgang Sieghart; Thomas Reiberger; Michael Trauner; Thomas Soliman; Gabriela Berlakovich; Matthias Pinter
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

Review 7.  Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation.

Authors:  Maria J Citores; Jose L Lucena; Sara de la Fuente; Valentin Cuervas-Mons
Journal:  World J Hepatol       Date:  2019-01-27

8.  Elevated Preoperative Serum Hs-CRP Level as a Prognostic Factor in Patients Who Underwent Resection for Hepatocellular Carcinoma.

Authors:  Yu-Bin Liu; Jie Ying; Su-Juan Kuang; Hao-Sheng Jin; Zi Yin; Liang Chang; Hui Yang; Ying-Liang Ou; Jiang-Hua Zheng; Wei-Dong Zhang; Chuan-Sheng Li; Zhi-Xiang Jian
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.